How to Do Market Research for a Femtech Product

Femtech market research runs through five steps: define a specific women's health segment, size demand with public data instead of a guess, map the competitive landscape past what an app store search shows you, confirm who actually pays, and listen to the patient communities already describing the problem online. Skip the segment step and every number you produce after it measures the wrong market.

Quick Answer: Don't try to size "the femtech market." Pick a life stage or condition, pull prevalence and utilization signals from public health data, map competitors beyond a keyword search, confirm whether the user, an employer, a clinic, or a payer foots the bill, and listen to the communities already talking about the problem. Do those five things in order and you'll have a defensible research base instead of a borrowed headline.

Before You Size Anything: Life Stage, Condition, and Care Context

Femtech research fails at the starting line more often than at any later step, because "women's health" quietly collapses several unrelated markets into one phrase. Before you open a single data source, pin down three things about the person and problem you're researching — otherwise every source you consult afterward answers a question you didn't actually ask.

• Life stage — adolescent and young adult, reproductive-age and fertility, pregnancy and postpartum, or perimenopause and menopause. Each stage has different clinicians, different care settings, and different urgency.
• Condition versus wellness use case — a diagnosed, managed condition (endometriosis, PCOS, a high-risk pregnancy) sits in a different evidence and regulatory category than a general wellness habit (cycle tracking, general fitness, sleep).
• Care context — whether the person is currently self-managing outside the healthcare system, already inside a clinical relationship, or somewhere in between deciding whether to seek care at all.

Write down where your idea sits on all three axes before you touch a data source. A pelvic-floor recovery product for postpartum mothers already under a physical therapist's care is a different research project — different prevalence data, different competitors, different payer — from a general cycle-tracking app aimed at any menstruating teenager. Confusing the two is the single fastest way to end up with numbers that sound authoritative and mean nothing for your actual product.

Step 1: Define Your Segment Before You Touch a Number

Your market research is only as good as the sentence that defines who it's about, and in femtech that sentence has to be specific enough to exclude almost everyone. "Women's health" is not a segment — it's a category with dozens of segments inside it, each with its own prevalence, competitors, and buyer.

The segment-narrowing discipline described in how to validate a femtech startup idea applies just as directly to research as it does to interviews: write your segment as one sentence — "postpartum mothers in their first six months recovering pelvic-floor strength," not "new mothers," and certainly not "women." That sentence becomes the filter for every number, every competitor, and every community you look at from this point forward.

This matters more in femtech than in most categories because the denominator changes so drastically depending on where you draw the line. "The market for menstrual health apps" and "the market for endometriosis diagnostic support among women already diagnosed" both technically fall under "femtech," but they describe populations that differ by orders of magnitude and require completely different research paths to size honestly. If you can't state your segment in one specific sentence, you're not ready to size demand yet — go back and narrow it first.

Step 2: Size Demand With Public Data, Not a Borrowed Headline

Build your demand estimate from named public sources you can point to, not from a market-size figure you saw quoted in a pitch deck or a press release. Femtech is a category where confident-sounding numbers circulate widely and get repeated without anyone tracing them back to a primary source — treat any figure you can't trace to a specific, named dataset as a guess wearing a costume.

The reliable approach combines two directions of estimate and checks them against each other. A top-down estimate starts from a population count and a prevalence or eligibility rate — how many people fall into your life-stage and condition segment — and narrows from there. A bottom-up estimate starts from something you can actually observe, like the patient volume of a handful of clinics that treat your segment, or the membership of a relevant patient community, and builds up. When the two land in the same neighborhood, you have a number worth trusting; when they diverge sharply, that gap is telling you something about your assumptions, not proof that one method is simply wrong.

For the specific public sources and what each one answers, see the free healthcare market data sources founders can use — most of what applies to healthcare broadly applies directly to femtech, since reproductive and women's health conditions are tracked inside the same government health datasets as everything else. What's specific to femtech is knowing which agencies and research organizations focus on women's health in particular; the table further down this article lists the ones worth starting with.

Step 3: Map the Competitor Landscape Past App Store Search

Search an app store category and you'll find some of your femtech competitors — but not the ones that matter most. A meaningful share of femtech competition is clinical, insurance-embedded, or entirely offline: a telehealth clinic, an employer benefits vendor, a specialist your prospective user already sees in person, or simply the workaround she's using today with no app at all. Missing that half of the landscape is how founders launch believing they're first to a problem that three well-funded competitors already serve through channels a keyword search never surfaces.

Work through competitor mapping from several angles instead of one:

• App store category browsing and review mining — read the negative reviews of adjacent products closely; a competitor's unresolved complaints are a map of the gap you might fill.
• Clinical trial registries like ClinicalTrials.gov, to see where pharmaceutical and clinical research attention is concentrating within your condition — a strong signal of where clinical-grade competition is headed.
• Professional association resources, such as guidance published by ACOG for obstetric and gynecological care, to understand the existing standard of care — the default "competitor" every femtech product has to out-perform even when no company sits behind it.
• Employer benefits marketplaces and directories, where women's health point solutions increasingly get distributed, to see who is already sold into the channel you might be planning to enter.
• Femtech-focused industry media and newsletters, which track funding announcements and new entrants far faster than a general search engine will.

Cross-reference what you find against your segment sentence from Step 1. A crowded competitor landscape for "women's health" broadly can still be wide open for your specific segment — and a landscape that looks empty at the category level can turn out to be full once you check the offline and clinical channels most competitor lists skip.

Step 4: Check the Payment Path Before You Build

Find out who actually pays before you spend a dollar building, because in femtech the person who uses the product and the person who funds it are frequently different people, and each payment path carries a completely different evidence bar. A direct-to-consumer wellness app only has to earn a user's card number. A product reimbursed through insurance has to fit an existing billing framework and defend a clinical claim. An employer-benefit product has to prove engagement and workforce outcomes to a buyer who never uses it personally.

Work through the realistic payment paths for your segment before committing to one:

Don't assume a billing code exists just because the clinical need is real — checking whether your service category maps to an existing procedure or service code is a concrete research task, not a guess, and it belongs in this step rather than after you've built something reimbursement was supposed to fund. If you're leaning toward the payer path, KFF's women's health policy research is a useful independent check on how coverage for your category actually looks today, separate from what a vendor's sales deck claims.

Step 5: Listen to the Communities Already Talking About This

Read before you build a single interview script, because patient communities online already contain more granular market signal for femtech than most closed surveys ever will. Women describe symptoms, workarounds, and frustration with existing products in their own language, unprompted, in condition-specific spaces — and that raw language tells you more about the real gap than a category-level statistic does.

Spend time in the places where your specific segment already gathers: condition-specific subreddits and Facebook groups, patient advocacy nonprofit forums, and the review sections of adjacent apps and services, not just your closest direct competitors. Read for patterns rather than posting your idea for feedback — a pitch dropped into a sensitive community reads as extraction, not participation, and can burn trust before you've earned any. Once you've identified real people worth talking to and a genuine pattern worth testing, the interview and synthesis techniques in the complete guide to customer research for founders apply directly — community listening tells you where the pain likely is; a structured interview is still how you confirm it's real and worth building for.

Public Data Sources for Women's Health Market Research

The table below lines up public sources worth checking against what each one is actually good for, so you don't pull a number from a source that wasn't built to answer your question.

None of these sources will hand you a finished market-sizing number for your specific segment — they hand you the prevalence, coverage, and policy inputs you combine into your own defensible estimate. Treat the table as a starting checklist, not a shortcut around Step 2's actual work of triangulating a top-down and bottom-up estimate against each other.

The Most Common Mistake: Sizing "All Women" Instead of a Segment

The single most common failure in femtech market research is quoting a total population — every woman of reproductive age, every menstruating person, every new mother — as if that were the addressable market for a narrow, specific product. It isn't. The real addressable population is the fraction defined by the segment sentence you wrote in Step 1, and that fraction is usually a small percentage of the headline number that made the pitch sound big.

A handful of related mistakes tend to travel together with this one:

• Treating prevalence as addressable market. Being diagnosed with a condition, or fitting a life-stage bucket, is not the same as being willing or able to adopt a specific product.
• Ignoring the cash-pay-versus-payer split when quoting a figure. A number that assumes insurance reimbursement means nothing if your product is actually cash-pay, and vice versa.
• Mistaking search interest for willingness to pay. High search volume around a symptom or condition tells you people are curious or concerned, not that they'll convert into paying customers.
• Counting only consumer apps as competitors. Missing the clinical, offline, and employer-benefit competition described in Step 3 leaves you blind to the players who actually shape the buyer's decision.
• Citing a market size with no traceable source behind it. If you can't point to the specific dataset and the calculation you ran on it, don't put the number in your plan — narrow the claim until you can.

The pattern underneath all five is the same: broad numbers feel more impressive and are almost always less true for your actual product. A smaller, defensible estimate you can explain line by line will serve you better in front of an investor, a co-founder, or your own decision-making than a large number nobody, including you, can trace back to its source.

Key Takeaways

• "Women's health" is a category, not a segment. Define life stage, condition, and care context before you open a single data source, or every later number answers the wrong question.
• Write your segment as one specific sentence. That sentence is the filter for every prevalence figure, every competitor, and every community you research afterward.
• Size demand with a named public source, not a borrowed headline. Triangulate a top-down population estimate against a bottom-up observed estimate, and treat a large gap between them as a signal to dig deeper.
• Competitors hide outside the app store. Clinical trials, professional associations, employer-benefit marketplaces, and the plain status quo all compete with you even when no app represents them.
• Map the payment path before you build. A cash-pay, employer, clinic, and payer path each carry a different evidence bar — confirm which one you're actually building for.
• Community listening beats a cold survey. Read patient communities for real language and real frustration before you write a single interview question.
• Never quote a market number you can't trace to a source. If you can't name the dataset and the calculation, the number is a guess — narrow the claim instead of inflating it.

Frequently Asked Questions

How big is the femtech market?

There is no single trustworthy public figure for "the femtech market" as a whole — industry estimates vary widely between reports and change from year to year depending on what each analyst chooses to include. The reliable approach is building your own segment-specific estimate from named prevalence and utilization data, as described in Step 2, rather than quoting a category-wide number that doesn't map to your actual product.

Where can I find femtech market data for free?

Start with government health agencies (CDC, NIH, HHS), independent research organizations focused on reproductive health like the Guttmacher Institute, and professional associations such as ACOG for clinical context. The table above lists the core starting points, and the free healthcare market data sources founders can use covers the broader set of public healthcare datasets that apply directly to women's health conditions as well.

How do I find femtech competitors that don't show up on Crunchbase?

Look past funding trackers into app store review sections, ClinicalTrials.gov for clinical-stage competition, employer benefits marketplaces, and professional association directories. A significant share of femtech competition is clinical or offline and simply doesn't surface in a startup-funding database, which is why competitor mapping in this category has to combine several source types rather than one search.

Do I need to research FDA or health-data regulation alongside market research?

Often yes, but it depends entirely on what your product claims and what data it handles — a product making clinical claims or touching regulated health data may fall under medical-device or health-privacy rules, while a general wellness product may not. Regulatory categories are specific to your product and jurisdiction, so treat this as a signal to consult a qualified regulatory or privacy advisor early rather than something a market-research pass alone can resolve.